Fig. 3From: Ionizable drug delivery systems for efficient and selective gene therapyDiscovery and progress schedule of nucleic acid technology and applications. FDA Food and Drug Administration, ILNP ionizable lipid nanoparticle, RNAi RNA interference, mRNA messenger RNA, siRNA small interfering RNA, COVID-19 coronavirus disease 2019, DODAP 1,2-dioleoyl-3-dimethylammonium-propane, DLinDMA 1,2-dilinoleyloxy-N,N-dimethyl-3-aminopropaneBack to article page